Cite
RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC
MLA
Chan-Gi Pack, et al. “RNA-Binding Protein NONO Contributes to Cancer Cell Growth and Confers Drug Resistance as a Theranostic Target in TNBC.” Theranostics, vol. 10, Jan. 2020, pp. 7974–92. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....119fc75a722b120cef5a751bba0a956b&authtype=sso&custid=ns315887.
APA
Chan-Gi Pack, Kum Kum Khanna, Prahlad V. Raninga, Seong-il Eyun, Gordon B. Mills, Young Ha Kim, Balázs Győrffy, Seong-Jin Kim, Myoung-Hee Kang, Hee Dong Han, Yun Yong Park, Jin Sung Ju, Hee Jin Lee, Yong Shin, Ji Won Eun, & Gyungyub Gong. (2020). RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC. Theranostics, 10, 7974–7992.
Chicago
Chan-Gi Pack, Kum Kum Khanna, Prahlad V. Raninga, Seong-il Eyun, Gordon B. Mills, Young Ha Kim, Balázs Győrffy, et al. 2020. “RNA-Binding Protein NONO Contributes to Cancer Cell Growth and Confers Drug Resistance as a Theranostic Target in TNBC.” Theranostics 10 (January): 7974–92. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....119fc75a722b120cef5a751bba0a956b&authtype=sso&custid=ns315887.